Arrowhead Research | ARWR - Stock

Stock Price
61.83
Daily Change
0.21 0.34%
Monthly
-7.59%
Yearly
226.45%
Q1 Forecast
61.62

Arrowhead Research reported $-173.08M in Stock for its fiscal quarter ending in December of 2024.





Stock Change Date
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Anika Therapeutics USD 16.28M 638K Sep/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Incyte USD 101.06M 17.61M Dec/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Ligand Pharmaceuticals USD 11.9M 3.59M Sep/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025